Gastric bypass in Type 2 diabetes with BMI < 30: Weight and weight loss have a major influence on outcomes

Diabetic Medicine

Volumn 30, Issue 4, 2013, Pages e127-e134

  Dixon, J B ^a,b   Hur, K Y ^c   Lee, Wei Jei ^d   Kim, M J ^c   Chong, K ^d   Chen, S C ^d   Straznicky, N E ^a   Zimmet, P ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c Soonchunhyang University   (South Korea)

^d MIN SHENG GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; BODY MASS; BODY WEIGHT LOSS; CLINICAL EFFECTIVENESS; CLINICAL OUTCOME; COHORT ANALYSIS; CORRELATION ANALYSIS; DISEASE DURATION; FEMALE; GASTRIC BYPASS SURGERY; GASTROINTESTINAL HEMORRHAGE; GLYCEMIC CONTROL; GOUT; HUMAN; JEJUNUM ULCER; LAPAROSCOPIC SURGERY; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPENIA; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REFLUX ESOPHAGITIS; ROUX-EN-Y GASTRIC BYPASS; SENSITIVITY AND SPECIFICITY; SOUTH KOREA; STATISTICAL ANALYSIS; STOMACH PARESIS; TAIWAN; TREATMENT OUTCOME; TREATMENT RESPONSE; URINARY TRACT INFECTION; WOUND INFECTION; BLOOD; DIET RESTRICTION; EVALUATION; GLUCOSE BLOOD LEVEL; LAPAROSCOPY; METABOLISM; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; STOMACH BYPASS; WEIGHT REDUCTION;

ADULT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; C-PEPTIDE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GASTRIC BYPASS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; WEIGHT LOSS; YOUNG ADULT;

EID: 84883538969     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12107     Document Type: Article

References (37)

1. Dixon JB, Zimmet P, Alberti KG, Rubino F. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med 2011; 28: 628–642.
2. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 222: 339–350.
3. Wickremesekera K, Miller G, Naotunne TD, Knowles G, Stubbs RS. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study. Obes Surg 2005; 15: 474–481.
4. Rubino F, Schauer PR, Kaplan LM, Cummings DE. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med 2010; 61: 393–411.
5. Laferrere B. Do we really know why diabetes remits after gastric bypass surgery? Endocrine 2011; 40: 162–167.
6. Lee WY, Park JS, Noh SY, Rhee EJ, Kim SW, Zimmet PZ. Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. Diabetes Res Clin Pract 2004; 65: 143–149.
7. Unwin N, Harland J, White M, Bhopal R, Winocour P, Stephenson P et al. Body mass index, waist circumference, waist-hip ratio, and glucose intolerance in Chinese and Europid adults in Newcastle, UK. J Epidemiol Community Health 1997; 51: 160–166.
8. World Health Organization.. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157–163.
9. Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011; 94: 311–321.
10. International Association for the Study of Obesity. Global prevalence of adult obesity (BMI ≥ 30 kg/m²): country rankings 2012. London: International Association for the Study of Obesity, 2012.
11. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467–484.
12. Dixon JB, O’Brien P. Health Outcomes of Severely Obese Type 2 Diabetic Subjects 1 Year After Laparoscopic Adjustable Gastric Banding. Diabetes Care 2002; 25: 358–363.
13. Lee WJ, Hur KY, Lakadawala M, Kasama K, Wong SK, Lee YC. Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional international study. J Gastrointest Surg 2012; 16: 45–51.
14. Hall TC, Pellen MG, Sedman PC, Jain PK. Preoperative factors predicting remission of Type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg 2010; 20: 1245–1250.
15. Lee WJ, Chong K, Ser KH, Chen JC, Lee YC, Chen SC et al. C-peptide predicts the remission of type 2 diabetes after bariatric surgery. Obes Surg 2012; 22: 293–298.
16. 2: a literature review. Diabetes Technol Ther 2012; 14: 365–372.
17. Kim JW, Cheong JH, Hyung WJ, Choi SH, Noh SH. Outcome after gastrectomy in gastric cancer patients with type 2 diabetes. World J Gastroenterol 2012; 18: 49–54.
18. 2): a prospective controlled study. Obes Surg 2011; 21: 880–888.
19. Scopinaro N, Adami GF, Papadia FS, Camerini G, Carlini F, Fried M et al. Effects of biliopanceratic diversion on type 2 diabetes in patients with BMI 25–35. Ann Surg 2011; 253: 699–703.
20. Klein S, Fabbrini E, Patterson BW, Polonsky KS, Schiavon CA, Correa JL et al. Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with Type 2 diabetes. Obesity (Silver Spring) 2012; 20: 1266–1272.
21. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012; 366: 1567– 1576.
22. Lee WJ, Yu PJ, Wang W, Chen TC, Wei PL, Huang MT. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg 2005; 242: 20–28.
23. Little RR, Rohlfing CL, Tennill AL, Madsen RW, Polonsky KS, Myers GL et al. Standardization of C-peptide measurements. Clin Chem 2008; 54: 1023–1026.
24. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122: 248–256.
25. Rubino F, R’Bibo SL, del Genio F, Mazumdar M, McGraw TE. Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol 2010; 6: 102–109.
26. DiGiorgi M, Rosen DJ, Choi JJ, Milone L, Schrope B, Olivero-Rivera L et al. Re-emergence of diabetes after gastric bypass in patients with mid-to long-term follow-up. Surg Obes Relat Dis 2010; 6: 249–253.
27. Mingrone G, Castagneto-Gissey L. Mechanisms of early improve-ment/resolution of type 2 diabetes after bariatric surgery. Diabetes Metab 2009; 35: 518–523.
28. Kadera BE, Lum K, Grant J, Pryor AD, Portenier DD, De Maria EJ. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss. Surg Obes Relat Dis 2009; 5: 305–309.
29. Schulman AP, del Genio F, Sinha N, Rubino F. ‘Metabolic’ surgery for treatment of type 2 diabetes mellitus. Endocr Pract 2009; 15: 624–631.
30. Cummings DE. Endocrine mechanisms mediating remission of diabetes after gastric bypass surgery. Int J Obes (Lond) 2009; 33 (Suppl 1): S33–S40.
31. Chikunguwo SM, Wolfe LG, Dodson P, Meador JG, Baugh N, Clore JN et al. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis 2010; 6: 254–259.
32. Camastra S, Gastaldelli A, Mari A, Bonuccelli S, Scartabelli G, Frascerra S et al. Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes. Diabetologia 2011; 54: 2093–2102.
33. Dixon JB, O’Brien PE. Changes in comorbidities and improvements in quality of life after LAP-BAND placement. Am J Surg 2002; 184: S51–S54.
34. Kolotkin RL, Crosby RD, Gress RE, Hunt SC, Adams TD. Two-year changes in health-related quality of life in gastric bypass patients compared with severely obese controls. Surg Obes Relat Dis 2009; 5: 250–256.
35. Huang CK, Shabbir A, Lo CH, Tai CM, Chen YS, Houng JY. Laparoscopic Roux-en-Y gastric bypass for the treatment of type II diabetes mellitus in Chinese patients with body mass index of 25– 35. Obes Surg 2011; 21: 1344–1349.
36. Pories WJ, MacDonald KG Jr, Morgan EJ, Sinha MK, Dohm GL, Swanson MS et al. Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr 1992; 55: 582S–585S.
37. Nannipieri M, Mari A, Anselmino M, Baldi S, Barsotti E, Guarino D et al. The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery. J Clin Endocrinol Metab 2011; 96: E1372–E1379.